{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:09:27Z","timestamp":1788365367309,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Genzyme-Sanofi to OGA","award":["GZ-2011-10820"],"award-info":[{"award-number":["GZ-2011-10820"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.bcmd.2016.02.003","type":"journal-article","created":{"date-parts":[[2016,2,15]],"date-time":"2016-02-15T02:47:09Z","timestamp":1455504429000},"page":"8-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Persistent immune alterations and comorbidities in splenectomized patients with Gaucher disease"],"prefix":"10.1016","volume":"59","author":[{"given":"S\u00f8ren Ulrik","family":"S\u00f8nder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renuka Pudi","family":"Limgala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita M.","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chidima","family":"Ioanou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Plassmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald E.","family":"Marti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oral","family":"Alpan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozlem","family":"Goker-Alpan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2016.02.003_bb0005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jceh.2014.02.005","article-title":"Gaucher disease","volume":"4","author":"Nagral","year":"2014","journal-title":"J. clin. exp. hepatol."},{"key":"10.1016\/j.bcmd.2016.02.003_bb0010","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2147\/TCRM.S6955","article-title":"Optimal therapy in Gaucher disease","volume":"6","author":"Goker-Alpan","year":"2010","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.bcmd.2016.02.003_bb0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1615\/CritRevOncog.2013004503","article-title":"Immunological cells and functions in Gaucher disease","volume":"18","author":"Pandey","year":"2013","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.bcmd.2016.02.003_bb0020","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13023-014-0112-x","article-title":"Modelling Gaucher disease progression: long-term enzyme replacement therapy reduces the incidence of splenectomy and bone complications","volume":"9","author":"van Dussen","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bcmd.2016.02.003_bb0025","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/jcp.32.10.1045","article-title":"Changes in T and B blood lymphocytes after splenectomy","volume":"32","author":"Millard","year":"1979","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bcmd.2016.02.003_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023164","article-title":"Splenectomy associated changes in IgM memory B cells in an adult spleen registry cohort","volume":"6","author":"Cameron","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2016.02.003_bb0035","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1084\/jem.20022020","article-title":"Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen","volume":"197","author":"Kruetzmann","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcmd.2016.02.003_bb0040","doi-asserted-by":"crossref","unstructured":"H. Wasserstrom, J. Bussel, L.C. Lim, C. Cunningham-Rundles, Memory B cells and pneumococcal antibody after splenectomy, Journal of Immunology (Baltimore MD : 1950), 181 (2008) 3684\u20133689.","DOI":"10.4049\/jimmunol.181.5.3684"},{"key":"10.1016\/j.bcmd.2016.02.003_bb0045","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/MD.0b013e3182057be4","article-title":"Osseous manifestations of adult Gaucher disease in the era of enzyme replacement therapy","volume":"90","author":"Deegan","year":"2011","journal-title":"Medicine"},{"key":"10.1016\/j.bcmd.2016.02.003_bb0050","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2141.2009.07872.x","article-title":"Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis","volume":"147","author":"Mistry","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2016.02.003_bb0055","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1096-7192(02)00122-1","article-title":"Pulmonary hypertension in type 1 Gaucher's disease: genetic and epigenetic determinants of phenotype and response to therapy","volume":"77","author":"Mistry","year":"2002","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcmd.2016.02.003_bb0060","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/ajh.21684","article-title":"Expanding spectrum of the association between Type 1 Gaucher disease and cancers: a series of patients with up to 3 sequential cancers of multiple types\u2014correlation with genotype and phenotype","volume":"85","author":"Lo","year":"2010","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2016.02.003_bb0065","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bcmd.2016.02.003_bb0070","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1006\/bcmd.1999.0237","article-title":"T cell numbers relate to bone involvement in Gaucher disease","volume":"25","author":"Lacerda","year":"1999","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2016.02.003_bb0075","article-title":"Pneumococcal conjugate vaccine use in adults","author":"Isturiz","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.bcmd.2016.02.003_bb0080","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1016\/j.vaccine.2015.10.114","article-title":"Response to pneumococcal polysaccharide vaccination in patients with chronic and allergic aspergillosis","volume":"33","author":"Kosmidis","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.bcmd.2016.02.003_bb0085","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(00)00229-5","article-title":"A practical approach to multicolor flow cytometry for immunophenotyping","volume":"243","author":"Baumgarth","year":"2000","journal-title":"J. Immunol. Methods"},{"issue":"Suppl. 1","key":"10.1016\/j.bcmd.2016.02.003_bb0090","first-page":"S19","article-title":"Long-term treatment outcomes in Gaucher disease","volume":"90","author":"Charrow","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2016.02.003_bb0095","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1182\/blood.V89.4.1288","article-title":"Evidence for a large compartment of IgM-expressing memory B cells in humans","volume":"89","author":"Klein","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2016.02.003_bb0100","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1084\/jem.188.9.1679","article-title":"Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells","volume":"188","author":"Klein","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcmd.2016.02.003_bb0105","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1182\/blood-2004-01-0346","article-title":"Human blood IgM \u201cmemory\u201d B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire","volume":"104","author":"Weller","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2016.02.003_bb0110","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.clim.2008.09.009","article-title":"Role of the spleen in peripheral memory B-cell homeostasis in patients with autoimmune thrombocytopenia purpura","volume":"130","author":"Martinez-Gamboa","year":"2009","journal-title":"Clin. Immunol. (Orlando, Fla.)"},{"key":"10.1016\/j.bcmd.2016.02.003_bb0115","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bcmd.2013.01.001","article-title":"Altered innate function of plasmacytoid dendritic cells restored by enzyme replacement therapy in Gaucher disease","volume":"50","author":"Braudeau","year":"2013","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2016.02.003_bb0120","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1084\/jem.186.9.1407","article-title":"Phenotypic and functional separation of memory and effector human CD8+ T cells","volume":"186","author":"Hamann","year":"1997","journal-title":"J. Exp. Med."},{"issue":"2006","key":"10.1016\/j.bcmd.2016.02.003_bb0125","first-page":"4051","article-title":"Effector T cell differentiation and memory T cell maintenance outside secondary lymphoid organs","volume":"176","author":"Obhrai","year":"1950","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcmd.2016.02.003_bb0130","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3389\/fimmu.2014.00568","article-title":"Splenectomy alters distribution and turnover but not numbers or protective capacity of de novo generated memory CD8 T-cells","volume":"5","author":"Kim","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcmd.2016.02.003_bb0135","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ajh.2830290403","article-title":"Polyclonal B-cell lymphocytosis and hypergammaglobulinemia in patients with Gaucher disease","volume":"29","author":"Marti","year":"1988","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2016.02.003_bb0140","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/(SICI)1096-8652(199603)51:3<234::AID-AJH9>3.0.CO;2-Y","article-title":"Coagulation abnormalities in patients with Gaucher's disease: effect of therapy","volume":"51","author":"Billett","year":"1996","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2016.02.003_bb0145","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF01541326","article-title":"Natural autoantibodies in sera of patients with Gaucher's disease","volume":"15","author":"Shoenfeld","year":"1995","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.bcmd.2016.02.003_bb0150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-122-1-199501010-00005","article-title":"Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources","volume":"122","author":"Grabowski","year":"1995","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bcmd.2016.02.003_bb0155","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.0105-2896.2009.00875.x","article-title":"Defining dendritic cells by conditional and constitutive cell ablation","volume":"234","author":"Bar-On","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bcmd.2016.02.003_bb0160","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nri3046","article-title":"Human dendritic cell deficiency: the missing ID?","volume":"11","author":"Collin","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcmd.2016.02.003_bb0165","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-074950","article-title":"The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting","volume":"31","author":"Merad","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bcmd.2016.02.003_bb0170","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.2214\/ajr.139.6.1202","article-title":"Accelerated skeletal deterioration after splenectomy in Gaucher type 1 disease","volume":"139","author":"Rose","year":"1982","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.bcmd.2016.02.003_bb0175","doi-asserted-by":"crossref","first-page":"601763","DOI":"10.1155\/2012\/601763","article-title":"The pathogenesis of nontraumatic osteonecrosis","volume":"2012","author":"Seamon","year":"2012","journal-title":"Arthritis"},{"key":"10.1016\/j.bcmd.2016.02.003_bb0180","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bcmd.2015.05.009","article-title":"Proinflammatory and proosteoclastogenic potential of peripheral blood mononuclear cells from Gaucher patients: implication for bone pathology","volume":"55","author":"Mucci","year":"2015","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2016.02.003_bb0185","doi-asserted-by":"crossref","first-page":"196702","DOI":"10.1155\/2015\/196702","article-title":"ADAMTS-7 exhibits elevated expression in cartilage of osteonecrosis of femoral head and has a positive correlation with TNF-alpha and NF-kappa B P65","volume":"2015","author":"Li","year":"2015","journal-title":"Mediat. Inflamm."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979616300110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979616300110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:31:27Z","timestamp":1761049887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979616300110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":37,"alternative-id":["S1079979616300110"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2016.02.003","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistent immune alterations and comorbidities in splenectomized patients with Gaucher disease","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2016.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}